{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:12:43Z","timestamp":1792062763686,"version":"4.4.0"},"reference-count":189,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary artery disease, stroke, peripheral artery disease and chronic renal insufficiency. Hypertensive heart disease can manifest as many cardiac arrhythmias, most commonly being atrial fibrillation (AF). Both supraventricular and ventricular arrhythmias may occur in hypertensive patients, especially in those with left ventricular hypertrophy (LVH) or HF. Also, some of the antihypertensive drugs commonly used to reduce blood pressure, such as thiazide diuretics, may result in electrolyte abnormalities (e.g. hypokalaemia, hypomagnesemia), further contributing to arrhythmias, whereas effective control of blood pressure may prevent the development of the arrhythmias such as AF. In recognizing this close relationship between hypertension and arrhythmias, the European Heart Rhythm Association (EHRA) and the European Society of Cardiology (ESC) Council on Hypertension convened a Task Force, with representation from the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLEACE), with the remit to comprehensively review the available evidence to publish a joint consensus document on hypertension and cardiac arrhythmias, and to provide up-to-date consensus recommendations for use in clinical practice. The ultimate judgment regarding care of a particular patient must be made by the healthcare provider and the patient in light of all of the circumstances presented by that patient.<\/jats:p>","DOI":"10.1093\/europace\/eux091","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T04:31:09Z","timestamp":1497933069000},"page":"891-911","source":"Crossref","is-referenced-by-count":143,"title":["Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLEACE)"],"prefix":"10.1093","volume":"19","author":[{"given":"Gregory Y. H.","family":"Lip","sequence":"first","affiliation":[{"name":"1Institute of Cardiovascular Sciences, University of Birmingham, UK"},{"name":"2Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Coca","sequence":"additional","affiliation":[{"name":"3Hypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Cl\u00ednic (IDIBAPS), University of Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kahan","sequence":"additional","affiliation":[{"name":"4Karolinska Institutet Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden"},{"name":"5Department of Cardiology, Danderyd University Hospital Corp, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"6Cardiology Department, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis S.","family":"Manolis","sequence":"additional","affiliation":[{"name":"7Third Department of Cardiology, Athens University School of Medicine, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Hecht","family":"Olsen","sequence":"additional","affiliation":[{"name":"8Department of Internal Medicine, Holbaek Hospital and Centre for Individualized Medicine in Arterial Diseases (CIMA), Odense University Hospital, University of Southern Denmark, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Oto","sequence":"additional","affiliation":[{"name":"9Department of Cardiology, Memorial Ankara Hospital, Heart and Health Foundation of Turkey, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana S.","family":"Potpara","sequence":"additional","affiliation":[{"name":"10School of Medicine, Cardiology Clinic, Clinical Centre of Serbia, Belgrade University, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Steffel","sequence":"additional","affiliation":[{"name":"11Electrophysiology and Cardiac Devices, Department of Cardiology, University Heart Center Zurich; Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mar\u00edn","sequence":"additional","affiliation":[{"name":"12Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, IMIB-Arrixaca, University of Murcia, Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio Jansen","family":"de Oliveira Figueiredo","sequence":"additional","affiliation":[{"name":"13Cardiology Department, Medicine School, State University of Campinas, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"de Simone","sequence":"additional","affiliation":[{"name":"14Department of Translational Medical Sciences, Federico II University Hospital, via S. Pansini 5, bld # 1, Napoli 80131, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Tzou","sequence":"additional","affiliation":[{"name":"15Cardiac Electrophysiology, Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chern-En","family":"Chiang","sequence":"additional","affiliation":[{"name":"16Division of Cardiology, Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Williams","sequence":"additional","affiliation":[{"name":"17Institute of Cardiovascular Science, University College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Reviewers:","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe-Andrei","family":"Dan","sequence":"additional","affiliation":[{"name":"18Colentina University Hospital, Medicine Faculty, University of Medicine \u201cCarol Davila\u201d-Bucharest Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Gorenek","sequence":"additional","affiliation":[{"name":"19Eskisehir Osmangazi University, Eskisehir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[{"name":"20Centre Hospitalier Universitaire Trousseau, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Savelieva","sequence":"additional","affiliation":[{"name":"21St George's University Of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hatala","sequence":"additional","affiliation":[{"name":"22National Cardiovascular Institute, NUSCH, Bratislava, Slovak Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"van Gelder","sequence":"additional","affiliation":[{"name":"23University of Groningen, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Brguljan-Hitij","sequence":"additional","affiliation":[{"name":"24University Medical Centre, Hypertension Department, Hospital Dr. Peter Drzaja, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Erdine","sequence":"additional","affiliation":[{"name":"25Istanbul University Cerrahpasa Medical School, Head of Hypertension Department, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan","family":"Lovi\u010d","sequence":"additional","affiliation":[{"name":"26Clinic for internal disease Intermedica, Cardiology department-Hypertension centere, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"27Korea University Medical Center, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Salinas-Arce","sequence":"additional","affiliation":[{"name":"28Cl\u00ednica Delgado, Miraflores, P\u00e9rou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Field","sequence":"additional","affiliation":[{"name":"29University of Wisconsin, Clinical Science Center, Madison, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,6,17]]},"reference":[{"key":"2026080923263825800_eux091-B1","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.amjcard.2015.03.026","article-title":"Improving clinical practice guidelines for practicing cardiologists","volume":"115","author":"Benhorin","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/jhh.2008.10","article-title":"Hypertension and cardiac arrhythmias: a review of the epidemiology, pathophysiology and clinical implications","volume":"22","author":"Yiu","year":"2008","journal-title":"J Hum Hypertens"},{"key":"2026080923263825800_eux091-B3","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/ajh.2012.75","article-title":"Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension","volume":"25","author":"Eguchi","year":"2012","journal-title":"Am J Hypertens"},{"key":"2026080923263825800_eux091-B4","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.33549\/physiolres.931101","article-title":"Adaptation of the heart to hypertension is associated with maladaptive gap junction connexin-43 remodeling","volume":"57","author":"Fialova","year":"2008","journal-title":"Physiol Res"},{"key":"2026080923263825800_eux091-B6","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/eurheartj\/ehp046","article-title":"Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles","volume":"30","author":"Goette","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jce.12578","article-title":"A prospective DE-MRI study evaluating the role of TGF-beta1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy","volume":"26","author":"Canpolat","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026080923263825800_eux091-B8","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.jacc.2015.03.557","article-title":"Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences","volume":"65","author":"Hirsh","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehw119","article-title":"Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation","volume":"38","author":"Spronk","year":"2016","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B10","doi-asserted-by":"crossref","first-page":"181S","DOI":"10.1016\/S0895-7061(99)00106-5","article-title":"Hypertension and sudden cardiac death","volume":"12","author":"Messerli","year":"1999","journal-title":"Am J Hypertens"},{"key":"2026080923263825800_eux091-B11","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/CIRCRESAHA.116.304679","article-title":"Cardiac innervation and sudden cardiac death","volume":"116","author":"Fukuda","year":"2015","journal-title":"Circ Res"},{"key":"2026080923263825800_eux091-B12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/anec.12003","article-title":"Electrocardiographic predictors of sudden cardiac death in patients with left ventricular hypertrophy","volume":"18","author":"Panikkath","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2026080923263825800_eux091-B13","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/hrt.2004.042473","article-title":"Left ventricular hypertrophy in hypertension: its arrhythmogenic potential","volume":"91","author":"Kahan","year":"2005","journal-title":"Heart"},{"key":"2026080923263825800_eux091-B14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11906-001-0040-8","article-title":"Are sleep-related breathing disorders important contributing factors to the production of essential hypertension?","volume":"3","author":"Silverberg","year":"2001","journal-title":"Curr Hypertens Rep"},{"key":"2026080923263825800_eux091-B15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1524-6175.2001.00491.x","article-title":"Obstructive sleep apnea and hypertension: from correlative to causative relationship","volume":"3","author":"Lavie","year":"2001","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026080923263825800_eux091-B16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(84)91107-3","article-title":"Sleep apnoea in a hypertensive population","volume":"2","author":"Kales","year":"1984","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1113\/eph8702336","article-title":"Hypertension-related intermyocyte junction remodelling is associated with a higher incidence of low-K(+)-induced lethal arrhythmias in isolated rat heart","volume":"87","author":"Tribulova","year":"2002","journal-title":"Exp Physiol"},{"key":"2026080923263825800_eux091-B18","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.pcad.2008.01.003","article-title":"The role of the autonomic nervous system in sudden cardiac death","volume":"50","author":"Vaseghi","year":"2008","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080923263825800_eux091-B20","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0895-7061(97)00127-1","article-title":"Increased prevalence of cardiac arrhythmias and transient episodes of myocardial ischemia in hypertensives with left ventricular hypertrophy but without clinical history of coronary heart disease","volume":"10","author":"Novo","year":"1997","journal-title":"Am J Hypertens"},{"key":"2026080923263825800_eux091-B21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1253\/jcj.64.499","article-title":"Cardiac arrhythmias and left ventricular hypertrophy in dipper and nondipper patients with essential hypertension","volume":"64","author":"Ijiri","year":"2000","journal-title":"Jpn Circ J"},{"key":"2026080923263825800_eux091-B22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/hrt.2005.069542","article-title":"Atrial extrasystoles after exercise predict atrial fibrillation in patients with left ventricular hypertrophy","volume":"92","author":"Folkeringa","year":"2006","journal-title":"Heart"},{"key":"2026080923263825800_eux091-B23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jacc.2015.05.018","article-title":"Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation","volume":"66","author":"Larsen","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B24","doi-asserted-by":"crossref","first-page":"e002519","DOI":"10.1161\/JAHA.112.002519","article-title":"Premature cardiac contractions and risk of incident ischemic stroke","volume":"1","author":"Ofoma","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"2026080923263825800_eux091-B25","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/STROKEAHA.115.008714","article-title":"Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE Trial","volume":"46","author":"Gladstone","year":"2015","journal-title":"Stroke"},{"key":"2026080923263825800_eux091-B26","doi-asserted-by":"crossref","first-page":"2n","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B27","doi-asserted-by":"crossref","first-page":"e63479","DOI":"10.1371\/journal.pone.0063479","article-title":"Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry","volume":"8","author":"Kakkar","year":"2013","journal-title":"PLoS One"},{"key":"2026080923263825800_eux091-B28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"Chiang","year":"2012","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"2026080923263825800_eux091-B29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B30","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/europace\/euu201","article-title":"Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry","volume":"17","author":"Lip","year":"2015","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B31","doi-asserted-by":"crossref","first-page":"20432","DOI":"10.1038\/srep20432","article-title":"Stroke prevention in atrial fibrillation and \u2032real world\u2032 adherence to guidelines in the Balkan Region: The BALKAN-AF Survey","volume":"6","author":"Potpara","year":"2016","journal-title":"Sci Rep"},{"key":"2026080923263825800_eux091-B32","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation\u2013Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B33","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B34","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","article-title":"Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century","volume":"167","author":"Ball","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080923263825800_eux091-B35","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1161\/CIRCULATIONAHA.108.830042","article-title":"Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women","volume":"119","author":"Conen","year":"2009","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/HYPERTENSIONAHA.111.179713","article-title":"Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study","volume":"59","author":"Grundvold","year":"2012","journal-title":"Hypertension"},{"key":"2026080923263825800_eux091-B37","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ajh.2008.248","article-title":"Blood pressure control and risk of incident atrial fibrillation","volume":"21","author":"Thomas","year":"2008","journal-title":"Am J Hypertens"},{"key":"2026080923263825800_eux091-B38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/eurheartj\/eht507","article-title":"Antihypertensive treatment and risk of atrial fibrillation: a nationwide study","volume":"35","author":"Marott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/HYPERTENSIONAHA.116.07901","article-title":"Atrial fibrillation in patients with hypertension: trajectories of risk factors in yet another manifestation of hypertensive target organ damage","volume":"68","author":"Lip","year":"2016","journal-title":"Hypertension"},{"key":"2026080923263825800_eux091-B40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.HYP.0000052830.02773.E4","article-title":"Atrial fibrillation in hypertension: predictors and outcome","volume":"41","author":"Verdecchia","year":"2003","journal-title":"Hypertension"},{"key":"2026080923263825800_eux091-B41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amjcard.2010.08.049","article-title":"A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)","volume":"107","author":"Chamberlain","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B43","doi-asserted-by":"crossref","first-page":"e000102","DOI":"10.1161\/JAHA.112.000102","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026080923263825800_eux091-B44","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1378\/chest.11-0340","article-title":"A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study","volume":"141","author":"Potpara","year":"2012","journal-title":"Chest"},{"key":"2026080923263825800_eux091-B46","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.hrthm.2015.04.008","article-title":"HATCH score in the prediction of new-onset atrial fibrillation after catheter ablation of typical atrial flutter","volume":"12","author":"Chen","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026080923263825800_eux091-B47","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"2026080923263825800_eux091-B48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2026080923263825800_eux091-B49","doi-asserted-by":"crossref","first-page":"e000250","DOI":"10.1161\/JAHA.113.000250","article-title":"A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score","volume":"2","author":"Singer","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026080923263825800_eux091-B50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"2026080923263825800_eux091-B51","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"2026080923263825800_eux091-B52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B53","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT(2)R(2) score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"2026080923263825800_eux091-B54","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B55","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/j.ijcard.2013.07.234","article-title":"A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study","volume":"168","author":"Potpara","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026080923263825800_eux091-B56","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.amjcard.2014.07.015","article-title":"Meta-analysis of left ventricular hypertrophy and sustained arrhythmias","volume":"114","author":"Chatterjee","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B57","first-page":"S42","article-title":"Combining other antihypertensive drugs with beta-blockers in hypertension: a focus on safety and tolerability","volume":"30","author":"Richards","year":"2014","journal-title":"Can J Cardiol"},{"key":"2026080923263825800_eux091-B58","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/pds.885","article-title":"Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting","volume":"12","author":"Almenoff","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026080923263825800_eux091-B59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM198608143150704","article-title":"Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial","volume":"315","author":"Gibson","year":"1986","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B60","first-page":"337","article-title":"KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"2","author":"Group KDIGOKBPW","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"2026080923263825800_eux091-B61","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1753944710381603","article-title":"Evaluation of left ventricular hypertrophy in patients requiring permanent pacing","volume":"4","author":"Alexopoulos","year":"2010","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2026080923263825800_eux091-B62","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/eurheartj\/ehl436","article-title":"Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study","volume":"28","author":"Rienstra","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1253\/jcj.47.573","article-title":"Histopathology of the conduction system in sudden cardiac death","volume":"47","author":"Okada","year":"1983","journal-title":"Jpn Circ J"},{"key":"2026080923263825800_eux091-B64","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jacc.2008.05.002","article-title":"Sleep apnea and cardiovascular disease: an American Heart Association\/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing","volume":"52","author":"Somers","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jelectrocard.2010.09.012","article-title":"Assessment of atrial conduction time in patients with essential hypertension","volume":"44","author":"Emiroglu","year":"2011","journal-title":"J Electrocardiol"},{"key":"2026080923263825800_eux091-B66","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1097\/HJH.0b013e3282fcc23c","article-title":"Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan intervention for endpoint reduction in hypertension study","volume":"26","author":"Li","year":"2008","journal-title":"J Hypertens"},{"key":"2026080923263825800_eux091-B67","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.HYP.0000125230.46080.c6","article-title":"QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study","volume":"43","author":"Oikarinen","year":"2004","journal-title":"Hypertension"},{"key":"2026080923263825800_eux091-B68","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jamainternmed.2016.2502","article-title":"Effect of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) on conduction system disease","volume":"176","author":"Dewland","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2026080923263825800_eux091-B69","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1093\/eurheartj\/ehp321","article-title":"QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study","volume":"30","author":"Morin","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0895-4356(99)00135-3","article-title":"Vital epidemiologic clues in heart failure","volume":"53","author":"Kannel","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"2026080923263825800_eux091-B71","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","article-title":"Resting heart rate in cardiovascular disease","volume":"50","author":"Fox","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B72","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B73","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjmed.2014.09.016","article-title":"Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease","volume":"128","author":"Bohm","year":"2015","journal-title":"Am J Med"},{"key":"2026080923263825800_eux091-B74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.acvd.2013.11.003","article-title":"Significance, prognostic value and management of heart rate in hypertension","volume":"107","author":"Courand","year":"2014","journal-title":"Arch Cardiovasc Dis"},{"key":"2026080923263825800_eux091-B75","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/eurheartj\/ehn123","article-title":"Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR\/trandolapril STudy (INVEST)","volume":"29","author":"Kolloch","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B76","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/eurheartj\/eht101","article-title":"Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials","volume":"34","author":"Fox","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10840-015-0034-0","article-title":"Conventional management of inappropriate sinus tachycardia","volume":"46","author":"Olshansky","year":"2016","journal-title":"J Interv Card Electrophysiol"},{"key":"2026080923263825800_eux091-B78","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/eurheartj\/eht208","article-title":"Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects: the PROOF-SYNAPSE study","volume":"34","author":"Chouchou","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B79","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(16)31258-2","article-title":"Rate control in atrial fibrillation","volume":"388","author":"Van Gelder","year":"2016","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchf.2012.09.002","article-title":"Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis","volume":"1","author":"Rienstra","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026080923263825800_eux091-B81","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/europace\/euv202","article-title":". Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society","volume":"17","author":"Boriani","year":"2015","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B82","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.amjcard.2009.04.040","article-title":"Meta-analysis of ablation of atrial flutter and supraventricular tachycardia","volume":"104","author":"Spector","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B83","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B84","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.114.014343","article-title":"Mass screening for untreated atrial fibrillation: the STROKESTOP study","volume":"131","author":"Svennberg","year":"2015","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B85","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.109.874982","article-title":"Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke","volume":"121","author":"Binici","year":"2010","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B86","first-page":"e1","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO)","volume":"50","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B87","first-page":"1","article-title":"Diving to the foot of an iceberg: the SEARCH for undiagnosed atrial fibrillation","volume":"112","author":"Potpara","year":"2014","journal-title":"Thromb Haemost"},{"key":"2026080923263825800_eux091-B88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH13-02-0165","article-title":"Screening to identify unknown atrial fibrillation. A systematic review","volume":"110","author":"Lowres","year":"2013","journal-title":"Thromb Haemost"},{"key":"2026080923263825800_eux091-B89","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1160\/TH14-03-0231","article-title":"Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study","volume":"111","author":"Lowres","year":"2014","journal-title":"Thromb Haemost"},{"key":"2026080923263825800_eux091-B90","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2015.06.488","article-title":"Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: The CARDIO-FIT Study","volume":"66","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B91","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B92","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/europace\/euw301","article-title":"European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular rrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci\u00f3n Cardiaca y Electrofisiologia (SOLAECE)","volume":"19","author":"Katritsis","year":"2017","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B93","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jacc.2003.08.013","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias\u2217 \u2014executive summary: a report of the American college of cardiology\/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society","volume":"42","author":"Blomstr\u00f6m-Lundqvist","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B94","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS Guideline for the Management of Adult Patients With Supraventricular TachycardiaA Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"67","author":"Page","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/11208210-000000000-00000","article-title":"Esmolol","volume":"72","author":"Garnock-Jones","year":"2012","journal-title":"Drugs"},{"key":"2026080923263825800_eux091-B96","article-title":"Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial","author":"Katritsis","year":"2017","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B97","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","article-title":"Stroke prevention in atrial fibrillation","volume":"388","author":"Freedman","year":"2016","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B98","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/STROKEAHA.116.013253","article-title":"Should atrial fibrillation patients with only 1 nongender-related CHA2DS2-VASc risk factor be anticoagulated?","volume":"47","author":"Fauchier","year":"2016","journal-title":"Stroke"},{"key":"2026080923263825800_eux091-B99","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1160\/TH15-07-0565","article-title":"Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy","volume":"114","author":"Lip","year":"2015","journal-title":"Thromb Haemost"},{"key":"2026080923263825800_eux091-B100","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/CIRCULATIONAHA.115.016713","article-title":"Should patients with atrial fibrillation and 1 stroke risk factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) be anticoagulated? yes: even 1 stroke risk factor confers a real risk of stroke","volume":"133","author":"Lip","year":"2016","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B101","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/ejhf.254","article-title":"Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on Atrial Fibrillation","volume":"17","author":"Lip","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026080923263825800_eux091-B102","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"Friberg","year":"2012","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B103","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/STROKEAHA.110.580506","article-title":"Blood pressure levels and bleeding events during antithrombotic therapy: the Bleeding with Antithrombotic Therapy (BAT) Study","volume":"41","author":"Toyoda","year":"2010","journal-title":"Stroke"},{"key":"2026080923263825800_eux091-B104","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B106","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B107","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"386","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B108","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.amjcard.2015.07.032","article-title":"Comparison of characteristics and outcomes of dabigatran versus warfarin in hypertensive patients with atrial fibrillation (from the RE-LY Trial)","volume":"116","author":"Nagarakanti","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B109","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002015","article-title":"Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial","volume":"4","author":"Rao","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2026080923263825800_eux091-B110","doi-asserted-by":"crossref","first-page":"e004549","DOI":"10.1161\/JAHA.112.004549","article-title":"Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis","volume":"2","author":"Ganesan","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026080923263825800_eux091-B111","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/eurheartj\/ehq079","article-title":"Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation","volume":"31","author":"Nault","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/pcad.2001.26966","article-title":"Pharmacologic conversion of atrial fibrillation: a systematic review of available evidence","volume":"44","author":"Slavik","year":"2001","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080923263825800_eux091-B113","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(16)31277-6","article-title":"Rhythm control in atrial fibrillation","volume":"388","author":"Piccini","year":"2016","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B114","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.300.15.1784","article-title":"Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial","volume":"300","author":"Ahmed","year":"2008","journal-title":"JAMA"},{"key":"2026080923263825800_eux091-B115","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/jth.13386","article-title":"Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores","volume":"14","author":"Lip","year":"2016","journal-title":"J Thromb Haemost"},{"key":"2026080923263825800_eux091-B116","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/01.CIR.85.5.1808","article-title":"Prevalence of circadian variations and spontaneous variability of cardiac disorders and ECG changes suggestive of myocardial ischemia in systemic arterial hypertension","volume":"85","author":"Zehender","year":"1992","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B117","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM198709243171302","article-title":"Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy","volume":"317","author":"McLenachan","year":"1987","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B118","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/eurheartj\/14.11.1548","article-title":"High blood pressure and ventricular arrhythmias","volume":"14","author":"Sideris","year":"1993","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B119","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9149(00)01271-6","article-title":"Association of ventricular premature complexes with electrocardiographic-estimated left ventricular mass in a population of African-American and white men and women (The Atherosclerosis Risk in Communities","volume":"87","author":"Simpson","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0002-9149(87)90305-5","article-title":"Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study","volume":"60","author":"Levy","year":"1987","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B121","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/europace\/euu362","article-title":"Ventricular arrhythmias in aortic valve stenosis before and after transcatheter aortic valve implantation","volume":"17","author":"Tempio","year":"2015","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B122","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.CIR.79.3.687","article-title":"Effect of acute volume load on refractoriness and arrhythmia development in isolated, chronically infarcted canine hearts","volume":"79","author":"Calkins","year":"1989","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B123","doi-asserted-by":"crossref","first-page":"141B","DOI":"10.1016\/S0735-1097(85)80545-3","article-title":"Sudden death: Lessons from subsets in population studies","volume":"5","author":"Kannel","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B124","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-108-1-7","article-title":"Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study","volume":"108","author":"Levy","year":"1988","journal-title":"Ann Int Med"},{"key":"2026080923263825800_eux091-B125","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B126","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0002-9149(02)02777-7","article-title":"Different actions of irbesartan and atenolol on cardiac repolarisation in hypertensive left ventricular hypertrophy","volume":"90","author":"Malmqvist","year":"2002","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B127","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/00004872-199611000-00014","article-title":"Alterations in left ventricular wall stress and coronary circulation in patients with isolated systolic hypertension","volume":"14","author":"Ohtsuka","year":"1996","journal-title":"J Hypertens"},{"key":"2026080923263825800_eux091-B128","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0895-7061(98)00036-3","article-title":"Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity","volume":"11","author":"Manolis","year":"1998","journal-title":"Am J Hypertens"},{"key":"2026080923263825800_eux091-B129","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0895-7061(01)01297-3","article-title":"Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH","volume":"14","author":"Novo","year":"2001","journal-title":"Am J Hypertens"},{"key":"2026080923263825800_eux091-B130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0895-7061(97)00041-1","article-title":"The effects on cardiac arrhythmias of antihypertensive therapy causing regression of left ventricular hypertrophy","volume":"10","author":"Mayet","year":"1997","journal-title":"Am J Hypertens"},{"key":"2026080923263825800_eux091-B131","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1001\/jama.1992.03480080053026","article-title":"Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men","volume":"267","author":"Siegel","year":"1992","journal-title":"JAMA"},{"key":"2026080923263825800_eux091-B132","first-page":"186","article-title":"Cardiac arrhythmias in hypertensive outpatients on various diuretics. Correlation between incidence and serum potassium and magnesium levels","volume":"18","author":"Lumme","year":"1986","journal-title":"Ann Clin Res"},{"key":"2026080923263825800_eux091-B133","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.666594","article-title":"Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death. The LIFE Study","volume":"116","author":"Wachtell","year":"2007","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B134","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1056\/NEJM199406303302603","article-title":"Diuretic therapy for hypertension and the risk of primary cardiac arrest","volume":"330","author":"Siscovick","year":"1994","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B135","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1472-8206.2010.00835.x","article-title":"Mechanisms of hypokalemia-induced ventricular arrhythmogenicity","volume":"24","author":"Osadchil","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"2026080923263825800_eux091-B136","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/HYPERTENSIONAHA.107.098475","article-title":"Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial","volume":"51","author":"Ogihara","year":"2008","journal-title":"Hypertension"},{"key":"2026080923263825800_eux091-B137","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(03)14183-9","article-title":"Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study","volume":"362","author":"Lindholm","year":"2003","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B138","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B139","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCEP.111.963348","article-title":"Premature ventricular contraction-induced cardiomyopathy: a treatable condition","volume":"5","author":"Lee","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026080923263825800_eux091-B140","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.hrthm.2010.03.036","article-title":"Relationship between burden of premature ventricular complexes and left ventricular function","volume":"7","author":"Baman","year":"2010","journal-title":"Heart Rhythm"},{"key":"2026080923263825800_eux091-B141","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.hrthm.2014.12.017","article-title":"Effect of ablation of frequent premature ventricular complexes on left ventricular function in patients with nonischemic cardiomyopathy","volume":"12","author":"El Kadri","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026080923263825800_eux091-B142","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.jhh.1000908","article-title":"QTc dispersion and complex ventricular arrhythmias in untreated newly presenting hypertensive patients","volume":"13","author":"Saadeh","year":"1999","journal-title":"J Hum Hypertens"},{"key":"2026080923263825800_eux091-B143","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1097\/00004872-199715120-00089","article-title":"Prognostic value of ventricular arrhythmias in systemic hypertension","volume":"15","author":"Galinier","year":"1997","journal-title":"J Hypertens"},{"key":"2026080923263825800_eux091-B144","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/europace\/euu194","article-title":"EHRA\/HRS\/APHRS expert consensus on ventricular arrhythmias","volume":"16","author":"Pedersen","year":"2014","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B145","first-page":"1601","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B146","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/europace\/eut084","article-title":". The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology","volume":"15","author":"Blomstrom Lundqvist","year":"2013","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B147","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1472-8206.2010.00853.x","article-title":"Role of drugs and devices in patients at risk of sudden cardiac death","volume":"24","author":"Boriani","year":"2010","journal-title":"Fundam Clin Pharmacol"},{"key":"2026080923263825800_eux091-B148","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-5273(92)90078-H","article-title":"The circadian profile of extrasystolic arrhythmia: its relationship to heart rate and blood pressure","volume":"34","author":"Sideris","year":"1992","journal-title":"Int J Cardiol"},{"key":"2026080923263825800_eux091-B149","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0002-9149(92)90792-W","article-title":"Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy","volume":"69","author":"Pringle","year":"1992","journal-title":"Am J Cardiol"},{"key":"2026080923263825800_eux091-B150","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B151","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/HYPERTENSIONAHA.109.136655","article-title":"Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies","volume":"54","author":"Fagard","year":"2009","journal-title":"Hypertension"},{"key":"2026080923263825800_eux091-B152","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"2026080923263825800_eux091-B153","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/europace\/eup098","article-title":"EHRA\/HRS expert consensus on catheter ablation of ventricular arrhythmias","volume":"11","author":"Aliot","year":"2009","journal-title":"Europace"},{"key":"2026080923263825800_eux091-B154","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"2026080923263825800_eux091-B155","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","article-title":"ACC\/AHA\/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons","volume":"51","author":"Epstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B156","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/HJH.0b013e3283331169","article-title":"Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study","volume":"28","author":"de Simone","year":"2010","journal-title":"J Hypertens"},{"key":"2026080923263825800_eux091-B157","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026080923263825800_eux091-B158","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijcard.2015.07.019","article-title":"Cardiovascular ultrasound exploration contributes to predict incident atrial fibrillation in arterial hypertension: the Campania Salute Network","volume":"199","author":"Losi","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026080923263825800_eux091-B159","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2147\/CIA.S81283","article-title":"Uncontrolled hypertension and orthostatic hypotension in relation to standing balance in elderly hypertensive patients","volume":"10","author":"Shen","year":"2015","journal-title":"Clin Interv Aging"},{"key":"2026080923263825800_eux091-B161","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3988\/jcn.2015.11.3.220","article-title":"Orthostatic hypotension: mechanisms, causes, management","volume":"11","author":"Low","year":"2015","journal-title":"J Clin Neurol"},{"key":"2026080923263825800_eux091-B162","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jacc.2015.06.1084","article-title":"Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment","volume":"66","author":"Ricci","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B163","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.115.05913","article-title":"Cardiac organ damage and arterial stiffness in autonomic failure: comparison with essential hypertension","volume":"66","author":"Milazzo","year":"2015","journal-title":"Hypertension"},{"key":"2026080923263825800_eux091-B164","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/jch.12726","article-title":"Arterial stiffness, central pulsatile hemodynamic load, and orthostatic hypotension","volume":"18","author":"Liu","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026080923263825800_eux091-B165","doi-asserted-by":"crossref","first-page":"e0146156","DOI":"10.1371\/journal.pone.0146156","article-title":"Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing","volume":"11","author":"Canney","year":"2016","journal-title":"PLoS One"},{"key":"2026080923263825800_eux091-B166","doi-asserted-by":"crossref","first-page":"e0128962","DOI":"10.1371\/journal.pone.0128962","article-title":"Orthostatic changes in hemodynamics and cardiovascular biomarkers in dysautonomic patients","volume":"10","author":"Nilsson","year":"2015","journal-title":"PLoS One"},{"key":"2026080923263825800_eux091-B167","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1586\/14779072.2015.1095090","article-title":"Orthostatic hypotension: managing a difficult problem","volume":"13","author":"Jones","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026080923263825800_eux091-B168","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH07-08-0508","article-title":"Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data","volume":"99","author":"Hughes","year":"2008","journal-title":"Thromb Haemost"},{"key":"2026080923263825800_eux091-B169","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review","volume":"69","author":"Stroke Risk in Atrial Fibrillation Working Group","year":"2007","journal-title":"Neurology"},{"key":"2026080923263825800_eux091-B170","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026080923263825800_eux091-B171","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2026080923263825800_eux091-B172","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1474-4422(13)70049-8","article-title":"Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies","volume":"12","author":"Lauer","year":"2013","journal-title":"Lancet Neurol"},{"key":"2026080923263825800_eux091-B173","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and disability from warfarin-associated intracranial and extracranial hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am J Med"},{"key":"2026080923263825800_eux091-B174","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/qjmed\/hcm076","article-title":"Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review","volume":"100","author":"Hughes","year":"2007","journal-title":"QJM"},{"key":"2026080923263825800_eux091-B175","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/eurheartj\/ehl504","article-title":"Effect of hypertension on anticoagulated patients with atrial fibrillation","volume":"28","author":"Lip","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B176","first-page":"336","article-title":"The Risk stratification and stroke prevention therapy care gap in Canadian atrial fibrillation patients","volume":"32","author":"Angaran","year":"2016","journal-title":"Can J Cardiol"},{"key":"2026080923263825800_eux091-B177","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/CIRCULATIONAHA.114.008643","article-title":". Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"129","author":"Steinberg","year":"2014","journal-title":"Circulation"},{"key":"2026080923263825800_eux091-B178","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1160\/TH11-05-0364","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a \u2032real world\u2032 nationwide cohort study","volume":"106","author":"Olesen","year":"2011","journal-title":"Thromb Haemost"},{"key":"2026080923263825800_eux091-B179","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1161\/CIRCOUTCOMES.110.958108","article-title":"Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation","volume":"4","author":"Eckman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026080923263825800_eux091-B180","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jacc.2015.01.044","article-title":"Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score","volume":"65","author":"Lip","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B181","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.11.046","article-title":"Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?","volume":"65","author":"Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026080923263825800_eux091-B182","first-page":"465","article-title":"Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation","volume":"111","author":"Lahaye","year":"2014","journal-title":"Thromb Haemost"},{"key":"2026080923263825800_eux091-B183","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1524-6175.2003.02463.x","article-title":"The economic impact of hypertension","volume":"5","author":"Elliott","year":"2003","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2026080923263825800_eux091-B184","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/eurheartj\/eht031","article-title":"Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association","volume":"34","author":"Boriani","year":"2013","journal-title":"Eur Heart J"},{"key":"2026080923263825800_eux091-B185","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/STROKEAHA.110.602235","article-title":"Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study","volume":"42","author":"Hannon","year":"2011","journal-title":"Stroke"},{"key":"2026080923263825800_eux091-B186","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1524-4733.2006.00160.x","article-title":"The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study","volume":"10","author":"Bruggenjurgen","year":"2007","journal-title":"Value Health"},{"key":"2026080923263825800_eux091-B187","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.022","article-title":". Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France","volume":"23","author":"Cotte","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026080923263825800_eux091-B188","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s40273-013-0090-1","article-title":"Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants","volume":"31","author":"Kasmeridis","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"2026080923263825800_eux091-B189","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/eurheartj\/ehu006","article-title":"Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation","volume":"35","author":"Dorian","year":"2014","journal-title":"Eur Heart J"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/19\/6\/891\/70576478\/europace_19_6_891.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/19\/6\/891\/70576478\/europace_19_6_891.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T03:37:22Z","timestamp":1786333042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/19\/6\/891\/3871445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":189,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eux091","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,6]]},"published":{"date-parts":[[2017,6,1]]}}}